HERTFORDSHIRE, England and PITTSBURGH, March 10, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that the company will present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2017, in Miami. The presentation is scheduled to begin at 9:30 a.m. ET.
Interested parties can access a live webcast of the presentation via the investor relations section of Mylan's Web site at www.mylan.com/investors. An archived version will also be available following the live presentation and can be accessed at the same location for a limited time.
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of approximately 7,500 marketed products around the world, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-barclays-global-healthcare-conference-300421919.html
SOURCE Mylan N.V.